Research graph
References from Review Areca Thirteen Pill (GY-13) for depression: a ConPhyMP-Informed critical review of material definition, pharmacological evidence, and translational Heyi-neuroplasticity-stress hypotheses. Local targets link to admitted publications; unresolved targets remain external evidence.
Preliminary analysis of the relationship between Mongolian medicine Heyi and depression
2014 · External reference
Areca thirteen pill improves depression in rat by modulation of the chemokine/chemokine receptor axis
10.1007/s12035-023-03855-1 · 2024 · External reference
Arecae semen: a comprehensive review of botany, traditional uses, phytochemistry, pharmacology, toxicology, and quality control
2024 · External reference
Effects of Mongolian medicine areca thirteen pill on hypothalamic-pituitary-adrenal axis negative feedback in chronic stress depression model rats
2014 · External reference
Mongolian medicine areca thirteen pill (GY-13) improved depressive syndrome via upregulating cAMP/PKA/CREB/BDNF signaling pathway
10.1016/j.jep.2022.115310 · 2022 · External reference
Comparative analysis on the efficacy of Binlang Shisanwei pill (Gaoyou-13) and its mechanism of treating depression from the perspective of Chinese and Mongolian medicine theory
2019 · External reference
Comparative efficacy and acceptability of 21 antidepressant drugs for adults with major depressive disorder: a systematic review and network meta-analysis
10.1016/s0140-6736(17)32802-7 · 2018 · External reference
A neurotrophic model for stress-related mood disorders
10.1016/j.biopsych.2006.02.013 · 2006 · External reference
Oral submucous fibrosis: review on mechanisms of malignant transformation
10.1016/j.oooo.2016.04.018 · 2016 · External reference
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
10.1016/j.neuroscience.2013.04.060 · 2013 · External reference
Best practice in research: overcoming common challenges in phytopharmacological research
10.1016/j.jep.2019.112230 · 2020 · External reference
Best practice in the chemical characterisation of extracts used in pharmacological and toxicological research: the ConPhyMP guidelines
10.3389/fphar.2022.953205 · 2022 · External reference
Discussion on the relationship between the onset time of Mongolian medical Heyi disease and depression
2016 · External reference
Investigating the mechanism of action of the Mongolian medicine areca thirteen pill (GY-13) in treating major depressive disorder based on integrated pharmacology
10.1097/md.0000000000042217 · 2025 · External reference
The role of inflammation in depression: from evolutionary imperative to modern treatment target
10.1038/nri.2015.5 · 2016 · External reference
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
10.1136/bmj.n71 · 2021 · External reference
The HPA axis in major depression: classical theories and new developments
10.1016/j.tins.2008.06.006 · 2008 · External reference
Stress, depression, and neuroplasticity: a convergence of mechanisms
10.1038/sj.npp.1301574 · 2008 · External reference
What is in a name? The need for accurate scientific nomenclature for plants
10.1016/j.jep.2013.12.022 · 2014 · External reference
Exploring traditional Mongolian materia medica: the path of progress from tradition to modernity
10.3389/fphar.2025.1554448 · 2025 · External reference
Clinical efficacy of Mongolian medicine areca thirteen pill combined with sertraline in treating mild to moderate depression
2025 · External reference
Effects of areca thirteen Pill on AC-cAMP-PKA signaling pathway in hippocampus and prefrontal cortex of depressive rats
External reference
Textual research on the formulation of Mongolian medicine Areca Thirteen Pill (Gaoyou-13)
External reference
Effects of Mongolian medicine Areca Thirteen Pill (Gaoyou-13) on behavior and monoamine neurotransmitters in different brain regions of depression model rats
External reference
Observation on the effects of Areca Thirteen Pill on behavior and hypothalamic-pituitary-adrenal axis in chronic stress depression model rats
2012 · External reference
PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation
10.7326/m18-0850 · 2018 · External reference
Areca nut and oral cancer: evidence from studies conducted in humans
10.1177/00220345221092751 · 2022 · External reference
Processed lateral root of Aconitum carmichaelii debx.: a review of cardiotonic effects and cardiotoxicity on molecular mechanisms
10.3389/fphar.2022.1026219 · 2022 · External reference
Areca thirteen pill improves depression in rat by modulation of the chemokine/chemokine receptor axis
10.1007/s12035-023-03855-1 · ExternalCitation · doi-reference
A neurotrophic model for stress-related mood disorders
10.1016/j.biopsych.2006.02.013 · ExternalCitation · doi-reference
What is in a name? The need for accurate scientific nomenclature for plants
10.1016/j.jep.2013.12.022 · ExternalCitation · doi-reference
Best practice in research: overcoming common challenges in phytopharmacological research
10.1016/j.jep.2019.112230 · ExternalCitation · doi-reference
Mongolian medicine areca thirteen pill (GY-13) improved depressive syndrome via upregulating cAMP/PKA/CREB/BDNF signaling pathway
10.1016/j.jep.2022.115310 · ExternalCitation · doi-reference
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
10.1016/j.neuroscience.2013.04.060 · ExternalCitation · doi-reference
Oral submucous fibrosis: review on mechanisms of malignant transformation
10.1016/j.oooo.2016.04.018 · ExternalCitation · doi-reference
The HPA axis in major depression: classical theories and new developments
10.1016/j.tins.2008.06.006 · ExternalCitation · doi-reference
Comparative efficacy and acceptability of 21 antidepressant drugs for adults with major depressive disorder: a systematic review and network meta-analysis
10.1016/s0140-6736(17)32802-7 · ExternalCitation · doi-reference
The role of inflammation in depression: from evolutionary imperative to modern treatment target
10.1038/nri.2015.5 · ExternalCitation · doi-reference
Stress, depression, and neuroplasticity: a convergence of mechanisms
10.1038/sj.npp.1301574 · ExternalCitation · doi-reference
Investigating the mechanism of action of the Mongolian medicine areca thirteen pill (GY-13) in treating major depressive disorder based on integrated pharmacology
10.1097/md.0000000000042217 · ExternalCitation · doi-reference
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
10.1136/bmj.n71 · ExternalCitation · doi-reference
Areca nut and oral cancer: evidence from studies conducted in humans
10.1177/00220345221092751 · ExternalCitation · doi-reference
Processed lateral root of Aconitum carmichaelii debx.: a review of cardiotonic effects and cardiotoxicity on molecular mechanisms
10.3389/fphar.2022.1026219 · ExternalCitation · doi-reference
Best practice in the chemical characterisation of extracts used in pharmacological and toxicological research: the ConPhyMP guidelines
10.3389/fphar.2022.953205 · ExternalCitation · doi-reference
Exploring traditional Mongolian materia medica: the path of progress from tradition to modernity
10.3389/fphar.2025.1554448 · ExternalCitation · doi-reference
PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation
10.7326/m18-0850 · ExternalCitation · doi-reference
